Background

Elon Musk co-founded Neuralink in 2016 as a company dedicated to developing high-bandwidth brain-computer interfaces. Alongside leading Tesla and SpaceX, Musk has positioned BCI development as essential to humanity’s future relationship with artificial intelligence.

Vision and Philosophy

Musk publicly articulates a vision of human-AI symbiosis, arguing that brain-computer interfaces represent a necessary technological pathway for humanity to maintain relevance as artificial intelligence capabilities advance. At Neuralink’s July 2019 launch presentation he argued that even a benign AI would leave humans behind, and that a high-bandwidth brain-machine interface would give people the option to keep up.

Strategic Direction

Under Musk’s leadership, Neuralink has pursued an aggressive commercialization timeline, combining venture capital funding exceeding $1 billion, including a $650 million Series E announced on 2 June 2025 at a reported pre-money valuation of about $9 billion, with development of proprietary robotic surgical systems and high-electrode-count neural arrays.

Influence on the Field

Musk’s profile brings Neuralink’s demonstrations and trial updates mainstream coverage well beyond the medical-device press. The company’s investors include sovereign funds: Qatar Investment Authority joined the Series E, and Oman Investment Authority announced a stake in May 2026.